$MANH
Manhattan Associates Inc

2017 Q2 Form 10-Q Financial Statement

#000156459017013865 Filed on July 24, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $154.1M $154.9M
YoY Change -0.48% 11.35%
Cost Of Revenue $62.31M $62.52M
YoY Change -0.33% 6.39%
Gross Profit $91.83M $92.38M
YoY Change -0.59% 14.97%
Gross Profit Margin 59.57% 59.64%
Selling, General & Admin $23.12M $24.38M
YoY Change -5.18% 2.38%
% of Gross Profit 25.18% 26.4%
Research & Development $14.10M $13.46M
YoY Change 4.79% 1.52%
% of Gross Profit 15.36% 14.57%
Depreciation & Amortization $2.300M $2.300M
YoY Change 0.0% 21.05%
% of Gross Profit 2.5% 2.49%
Operating Expenses $37.22M $37.84M
YoY Change -1.64% 2.07%
Operating Profit $49.26M $52.27M
YoY Change -5.76% 26.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$68.00K $654.0K
YoY Change -110.4% 82.17%
Pretax Income $49.19M $52.92M
YoY Change -7.05% 26.81%
Income Tax $18.05M $19.58M
% Of Pretax Income 36.69% 37.0%
Net Earnings $31.14M $33.34M
YoY Change -6.59% 28.21%
Net Earnings / Revenue 20.2% 21.53%
Basic Earnings Per Share $0.45 $0.46
Diluted Earnings Per Share $0.45 $0.46
COMMON SHARES
Basic Shares Outstanding 69.23M 71.88M
Diluted Shares Outstanding 69.42M 72.23M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.60M $95.20M
YoY Change -9.03% -12.18%
Cash & Equivalents $76.70M $93.14M
Short-Term Investments $9.900M $2.100M
Other Short-Term Assets $13.90M $11.80M
YoY Change 17.8% -39.18%
Inventory
Prepaid Expenses
Receivables $96.30M $93.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $196.8M $200.0M
YoY Change -1.6% -5.08%
LONG-TERM ASSETS
Property, Plant & Equipment $16.20M $20.90M
YoY Change -22.49% 6.63%
Goodwill $62.24M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.500M $7.111M
YoY Change 33.6% -8.83%
Total Long-Term Assets $87.90M $93.88M
YoY Change -6.37% 4.77%
TOTAL ASSETS
Total Short-Term Assets $196.8M $200.0M
Total Long-Term Assets $87.90M $93.88M
Total Assets $284.7M $293.9M
YoY Change -3.12% -2.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.20M $11.55M
YoY Change 14.33% 22.83%
Accrued Expenses $31.70M $32.90M
YoY Change -3.65% -2.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $117.9M $110.1M
YoY Change 7.08% 7.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.200M $8.789M
YoY Change 4.68% -35.38%
Total Long-Term Liabilities $9.200M $8.789M
YoY Change 4.68% -35.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $117.9M $110.1M
Total Long-Term Liabilities $9.200M $8.789M
Total Liabilities $127.0M $118.9M
YoY Change 6.82% 2.14%
SHAREHOLDERS EQUITY
Retained Earnings $188.4M
YoY Change
Common Stock $716.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.7M $175.0M
YoY Change
Total Liabilities & Shareholders Equity $284.7M $293.9M
YoY Change -3.12% -2.14%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $31.14M $33.34M
YoY Change -6.59% 28.21%
Depreciation, Depletion And Amortization $2.300M $2.300M
YoY Change 0.0% 21.05%
Cash From Operating Activities $11.30M $19.10M
YoY Change -40.84% -30.55%
INVESTING ACTIVITIES
Capital Expenditures -$1.900M -$2.200M
YoY Change -13.64% -18.52%
Acquisitions
YoY Change
Other Investing Activities $2.100M $6.700M
YoY Change -68.66% 294.12%
Cash From Investing Activities $200.0K $4.500M
YoY Change -95.56% -600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.00M -34.90M
YoY Change -28.37% 46.64%
NET CHANGE
Cash From Operating Activities 11.30M 19.10M
Cash From Investing Activities 200.0K 4.500M
Cash From Financing Activities -25.00M -34.90M
Net Change In Cash -13.50M -11.30M
YoY Change 19.47% -503.57%
FREE CASH FLOW
Cash From Operating Activities $11.30M $19.10M
Capital Expenditures -$1.900M -$2.200M
Free Cash Flow $13.20M $21.30M
YoY Change -38.03% -29.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Licenses Revenue
LicensesRevenue
22442000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
154141000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
154892000
CY2017Q2 us-gaap License Costs
LicenseCosts
2355000
CY2016Q2 us-gaap License Costs
LicenseCosts
2283000
CY2017Q2 us-gaap Cost Of Services
CostOfServices
47751000
CY2016Q2 us-gaap Cost Of Services
CostOfServices
48393000
CY2017Q2 manh Cost Of Hardware And Other
CostOfHardwareAndOther
12207000
CY2016Q2 manh Cost Of Hardware And Other
CostOfHardwareAndOther
11841000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14102000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13458000
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11732000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12015000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11387000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12368000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2326000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2266000
CY2017Q2 us-gaap Restructuring Charges
RestructuringCharges
3022000
us-gaap Restructuring Charges
RestructuringCharges
3022000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5074000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
950000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3588000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
124234000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7268000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
81620000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9336000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8549000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4577000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
72595000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
59507000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2703000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4107000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
9457000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8113000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12160000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4006000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
92812000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5074000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-81620000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-87720000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2274000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1074000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18911000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-25281000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118416000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93135000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
195492000
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
167933000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15934000
CY2016 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
5209000
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
532000
CY2016Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
4900000
us-gaap Reimbursement Revenue
ReimbursementRevenue
8800000
us-gaap Reimbursement Revenue
ReimbursementRevenue
9100000
CY2017Q2 us-gaap Cash
Cash
63300000
CY2017Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13400000
CY2017Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
4500000
CY2017Q2 us-gaap Long Term Investments
LongTermInvestments
0
CY2017Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
10500000
CY2016Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
30300000
CY2017Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
2800000
CY2016Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
3500000
us-gaap Restricted Stock Expense
RestrictedStockExpense
7300000
us-gaap Restricted Stock Expense
RestrictedStockExpense
8200000
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.367
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.344
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370
manh Excess Tax Benefit Related To Restricted Stock Vesting
ExcessTaxBenefitRelatedToRestrictedStockVesting
1900000
CY2017Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
194000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
348000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
234000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
369000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
62313000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
62517000
CY2017Q2 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
37221000
CY2016Q2 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
37841000
us-gaap Cost Of Revenue
CostOfRevenue
123934000
us-gaap Cost Of Revenue
CostOfRevenue
127330000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
75107000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
77583000
CY2017Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
80869000
CY2016Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
86992000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
156326000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
171498000
CY2017Q2 us-gaap Maintenance Revenue
MaintenanceRevenue
35959000
CY2016Q2 us-gaap Maintenance Revenue
MaintenanceRevenue
32841000
us-gaap Maintenance Revenue
MaintenanceRevenue
69335000
us-gaap Maintenance Revenue
MaintenanceRevenue
64598000
CY2017Q2 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
100
CY2017Q2 manh Restructuring Charges After Tax
RestructuringChargesAfterTax
1900000
CY2017Q2 manh Restructuring Charges Per Diluted Share
RestructuringChargesPerDilutedShare
0.03
us-gaap Payments For Restructuring
PaymentsForRestructuring
1284000
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
1738000

Files In Submission

Name View Source Status
0001564590-17-013865-index-headers.html Edgar Link pending
0001564590-17-013865-index.html Edgar Link pending
0001564590-17-013865.txt Edgar Link pending
0001564590-17-013865-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
manh-10q_20170630.htm Edgar Link pending
manh-20170630.xml Edgar Link completed
manh-20170630.xsd Edgar Link pending
manh-20170630_cal.xml Edgar Link unprocessable
manh-20170630_def.xml Edgar Link unprocessable
manh-20170630_lab.xml Edgar Link unprocessable
manh-20170630_pre.xml Edgar Link unprocessable
manh-ex311_6.htm Edgar Link pending
manh-ex312_8.htm Edgar Link pending
manh-ex32_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending